Efficacy, Safety and Tolerability of AEB071 Versus Cyclosporine in the Novo Renal Transplant Recipients
Status:
Completed
Trial end date:
2011-04-01
Target enrollment:
Participant gender:
Summary
This study will assess safety and efficacy of AEB071 combined with everolimus in a CNI-free
(calcineurin inhibitor) regimen in renal transplant recipients.